Modular Nanorobots for Cancer Cell Targeting

A recent study conducted by a team at the University of Basel, Switzerland, has introduced a groundbreaking advancement in the field of nanotechnology: a modular nanorobot capable of self-assembly, targeting cancer cells, and significantly reducing their viability. This development holds promise for applications in both medical and industrial fields, potentially transforming how we approach drug delivery and environmental management.

Overview of Nanorobot Technology

Nanorobots, often seen as the stuff of science fiction, have become a tangible reality, marking a significant leap in the rapidly advancing discipline of nanorobotics. Unlike traditional larger machines that incorporate electronics and software, these intricate devices are constructed from biomolecules and nanoparticles. Led by Prof. Dr. Cornelia Palivan, the research team has crafted a versatile nanorobot that consists of a propulsion module and a payload capsule, which together exhibit functional adaptability far beyond existing systems.

Modular Design and Functionality

The newly developed nanorobot features a structure reminiscent of a lunar rocket, comprising two key modules:

• Magnetic Propulsion Module: This component allows movement through magnetic manipulation, providing a means for the robot to navigate toward target locations.
• Payload Capsule: This capsule serves the critical function of carrying therapeutic agents or enzymes, ensuring efficient transport to specific cellular sites.

In previous research, Palivan's team had already established nanoscale polymer vesicles that effectively protect and deliver encapsulated enzymes. These vesicles allow small molecules to enter, undergo enzymatic processing, and release products into the surrounding medium.

Self-Assembly Mechanism

Connecting both modules is a unique "velcro fastener" made of complementary DNA strands, which enables the self-assembly of the propulsion module and the payload capsule. This design feature ensures a stable coupling while allowing programmability in assembly. To enhance docking capabilities to specific cells or surfaces, additional biomolecules are incorporated into the payload capsule. Testing with human cancer cell lines has shown promising results, indicating a successful accumulation of nanorobots on cell surfaces.

Targeting Cancer Cells

The effectiveness of the nanorobots was tested against HeLa cancer cells, where they were loaded with fluorescent markers to track their performance. Results revealed that the robots induced a dramatic reduction in cell viability, down to 16% within a 72-hour period. Dr. Voichita Mihali, the primary author of the study, pointed out that this localized effect can leverage concentrated drug action directly on cancerous cells, increasing therapeutic efficacy while minimizing side effects.

Reusability and Future Applications

One of the standout features of this modular system is its potential for reuse. Because the propulsion module is magnetic, the nanorobots can be retrieved upon completing their task, allowing for the refilling of payload capsules without the need for new materials. The implications for various applications include:

Conclusion

The development of this modular nanorobot represents a significant stride toward creating multifunctional tools that can address complex challenges across multiple domains. While the application in human medicine remains a future goal, the system’s ability to adapt by altering payload capsules hints at a plethora of possibilities in biomedical engineering and beyond.

Publication Details

Voichita Mihali et al, "Multiplex Modular Nanorobotic Systems with Catalytic Activity under Magnetic Navigation," Advanced Functional Materials (2026).

References

[1] Mihali, V., et al. (2026). Multiplex Modular Nanorobotic Systems with Catalytic Activity under Magnetic Navigation. _Advanced Functional Materials_. https://doi.org/10.1002/adfm.202600079

[2] University of Basel. "Nanorobot Technology Explored." University Publication, June 2026.